Nutex Health director granted 823 RSUs

Grenas Cheryl Yvonne reported acquisition or exercise transactions in this Form 4 filing.

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Grenas Cheryl Yvonne reported acquisition or exercise transactions in this Form 4 filing.

Nutex Health Inc. director Cheryl Yvonne Grenas received a grant of 823 Restricted Stock Units (RSUs), each representing one share of common stock upon vesting. The RSUs vest 100% on April 23, 2027, with pro-rata vesting if she leaves the company without cause before that date. Following this award, she holds 1,426 RSUs directly.

Insider Trade Summary

Grant/Award: 823 shares

Grant/Award 1 txn

Insider Grenas Cheryl Yvonne

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units (RSUs)	823	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units (RSUs) — 1,426 contracts (Direct)

Footnotes (2)

F1. Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.
F2. On April 23, 2026, the Reporting Person was granted 823 RSUs, which vest 100% on April 23, 2027. If the Reporting Person leaves service with Company without cause, during the vesting period, the RSUs shall vest on a pro-rata basis for the actual time in service for the Company.

Key Figures

RSUs granted: 823 RSUs Total RSUs after grant: 1,426 RSUs Vesting date: April 23, 2027 +1 more

4 metrics

RSUs granted 823 RSUs Grant on April 23, 2026

Total RSUs after grant 1,426 RSUs Holdings following transaction

Vesting date April 23, 2027 RSUs vest 100% on this date

Par value per share $0.001 Common stock underlying RSUs

Key Terms

Restricted Stock Units (RSUs), vesting, par value

3 terms

Restricted Stock Units (RSUs) financial

"Each RSU represents a contingence right to receive one share of the issuer's common stock"

Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.

vesting financial

"823 RSUs, which vest 100% on April 23, 2027"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

par value financial

"issuer's common stock, $0.001 par value, upon vesting"

Par value is the fixed amount printed on a bond or stock that represents its original value when issued. It’s like the face value of a coin or bill—what the issuer promises to pay back or the starting price of a stock—though it often doesn’t change with market prices. It matters because it helps determine certain financial details, like how much the company will pay back at maturity.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Nutex Health (NUTX) report for Cheryl Yvonne Grenas?

Nutex Health reported that director Cheryl Yvonne Grenas received a grant of 823 Restricted Stock Units (RSUs). These RSUs are a form of equity compensation that convert into common shares when they vest, aligning her interests with long-term shareholder value.

When do Cheryl Yvonne Grenas’s 823 RSUs at Nutex Health (NUTX) vest?

The 823 RSUs granted to Cheryl Yvonne Grenas vest 100% on April 23, 2027. At that time, each RSU converts into one share of Nutex Health common stock, assuming she continues her service with the company through the vesting date.

What happens to the Nutex Health (NUTX) RSUs if Cheryl Grenas leaves before vesting?

If Cheryl Yvonne Grenas leaves Nutex Health without cause during the vesting period, her 823 RSUs vest on a pro-rata basis. The vested amount is determined by how long she actually served the company between the grant date and her departure.

How many RSUs does Cheryl Yvonne Grenas hold after this Nutex Health (NUTX) grant?

After the April 23, 2026 award of 823 RSUs, Cheryl Yvonne Grenas holds a total of 1,426 RSUs. These units represent future rights to receive the company’s common stock as they vest under the grant’s terms.

What does each Nutex Health (NUTX) RSU granted to Cheryl Grenas represent?

Each Restricted Stock Unit granted to Cheryl Yvonne Grenas represents a contingent right to receive one share of Nutex Health common stock. The shares are issued only when the RSUs vest, providing equity compensation without upfront share issuance.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 04/24/2026 - 02:21 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Grenas Cheryl Yvonne

(Last)

(First)

(Middle)

1776 YORKTOWN STREET SUITE 700

C/O NUTEX HEALTH INC.

(Street)

HOUSTON

TEXAS

77056

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Nutex Health Inc. [ NUTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units (RSUs)	$0⁽¹⁾	04/23/2026		A		823⁽¹⁾		04/23/2027⁽²⁾	04/23/2027⁽²⁾	Common Stock	823	$0⁽¹⁾	1,426	D

Explanation of Responses:

1. Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

2. On April 23, 2026, the Reporting Person was granted 823 RSUs, which vest 100% on April 23, 2027. If the Reporting Person leaves service with Company without cause, during the vesting period, the RSUs shall vest on a pro-rata basis for the actual time in service for the Company.

	/s/ Cheryl Grenas	04/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR